IDG's CIO magazine announced Array BioPharma Inc. (NASDAQ: ARRY)
as a recipient of the 2009 CIO 100. The 22nd annual award program
recognizes organizations around the world that exemplify the highest
level of operational and strategic excellence in information technology
(IT).
“This year's CIO 100 awards draws well-deserved attention to companies
that are both innovating and creating business value with IT despite the
economic downturn,” said Maryfran Johnson, Editor in Chief of CIO
magazine & events. “These winners are an inspiration to businesses
everywhere.”
“We are excited to be recognized for our cutting-edge IT capabilities,”
said James Rizzi, Ph.D., Senior Director, Computational Technology. “We
believe these capabilities provide Array with a competitive advantage
over other biotech and pharmaceutical companies. Our recent initiative
to expand our paperless research environment into the development and
clinical arena was the basis for this recognition. In collaboration with
Medidata Solutions and General Dynamics Viz, we have incorporated an
innovative solution that provides our clinical scientists with real-time
data that enables critical decision-making across our portfolio.
Receiving this award validates not only our approach, but that we have
achieved a solution that is unique in the industry.”
The 2009 CIO 100 awards will be presented at the Broadmoor in Colorado
Springs, Colorado, on August 25 at the conclusion of the eleventh annual
CIO 100 Symposium® and Awards Ceremony.
About the CIO 100
The recipients of this year's CIO 100 award were selected through a
three-step process. First, companies filled out an online application
form detailing their innovative practices in both business and IT. Next,
a team of judges reviewed the applications in depth, looking for unique
practices and substantial results. Finally, CIO editors reviewed
the judges' recommendations and voted on the final 100. Once the top 100
honorees were selected, several honorees were chosen to receive an
additional special award.
Complete coverage of the 2009 CIO 100 awards will be on www.cio.com
after June 1, 2009 and in the August 1st issue of CIO magazine.
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small molecule
drugs to treat patients afflicted with cancer, inflammatory and
metabolic diseases.
